Publications

Home
Publications

Patient characteristics and incidence of in-hospital events in spontaneous coronary artery dissection and suspected concurrent Takotsubo syndrome: A report of the iSCAD registry
Published on 2026-05-26 First Author Gerald Chi
Design of VICTORION-2 Prevent: a randomized double-blind, placebo-controlled trial, assessing the impact of inclisiran on major adverse cardiovascular events in patients with established cardiovascular disease
Published on 2026-05-26 First Author Ph Gabriel Steg
Obicetrapib and lipoprotein(a) levels in patients at high cardiovascular risk: a pooled analysis of trials
Published on 2026-05-24 First Author Stephen J Nicholls
Interleukin-6 and C-reactive protein prognostic value following acute coronary syndrome
Published on 2026-05-24 First Author Johan Wouter Jukema
Misclassification of type 1 diabetes as type 2 diabetes in adults: practical guidance for screening and diagnosis for primary care providers
Published on 2026-05-18 First Author Eugene E Wright
Cardiovascular Regulatory Science: Accelerating the Path from Bench to Bedside
Published on 2026-05-16 First Author Serge Korjian
Long-Term Outcomes of a Drug-Eluting Resorbable Scaffold vs Angioplasty in Infrapopliteal Chronic Limb-Threatening Ischemia: 3-Year Results From the LIFE-BTK Trial
Published on 2026-05-12 First Author Sahil A Parikh
Efficacy of Short Course Cognitive Behavioral Therapy on Stress Reduction Among First-Year Surgical Residents
Published on 2026-05-06 First Author George Burnet
Thyroid Function with Continuous KRT: A Prospective Study
Published on 2026-05-03 First Author Matthew Kennis
Secondary Prevention Strategies For Patients with Lower Extremity Peripheral Artery Disease After Successful Peripheral Vascular Intervention
Published on 2026-05-01 First Author Pishoy Gouda
Health care resource utilization and costs of major bleeding in patients with and without dialysis-dependent end-stage kidney disease: a retrospective study
Published on 2026-04-22 First Author Nicholas S Roetker
Acute Estimated Glomerular Filtration Rate Decline After Initiation of Therapies That Slow Kidney Disease Progression: Clinical Practice Implications
Published on 2026-04-21 First Author David Z I Cherney
The emerging role of CETP inhibition in the prevention of Alzheimer's disease
Published on 2026-04-19 First Author Michael H Davidson
Factors associated with a complicated hospital course in patients with spontaneous coronary artery dissection: a report of the iSCAD registry
Published on 2026-04-17 First Author Fahad Alkhalfan
Author Correction: Obicetrapib in patients with heterozygous familial hypercholesterolemia: the BROOKLYN randomized clinical trial
Published on 2026-04-16 First Author Stephen J Nicholls
The AHA/ACC Guideline for Pulmonary Embolism: A New Era in Diagnosis, Risk Assessment, and Management
Published on 2026-04-07 First Author Behnood Bikdeli
Relationship Between Achieved LDL-C and Saphenous Vein Graft Patency: A Post Hoc Analysis of the NEWTON-CABG CardioLink-5 Study
Published on 2026-03-30 First Author Michael Szarek
Obicetrapib and ezetimibe enhance LDL receptor-mediated VLDL clearance and regress atherosclerosis on atorvastatin background
Published on 2026-03-25 First Author José A Inia
ANSWER-HF: sacubitril-valsartan reduces NT-proBNP in heart failure due to Chagas cardiomyopathy despite no reverse remodeling
Published on 2026-03-22 First Author Eduardo Bello Martins
American Association of Clinical Endocrinology Consensus Statement: Algorithm for Management of Adults With Type 2 Diabetes - 2026 Update
Published on 2026-03-16 First Author Susan L Samson
Semaglutide in peripheral artery disease and diabetes by baseline disease severity and age: the STRIDE trial
Published on 2026-03-03 First Author Joakim Nordanstig
Sotagliflozin, suPAR, and Cardiovascular Outcomes in Patients With Diabetes and Heart Failure: A SOLOIST-WHF Ancillary Study
Published on 2026-03-01 First Author Anis Ismail
Low-Dose Rivaroxaban Plus Aspirin in Patients With PAD Undergoing Lower Extremity Revascularization With and Without History of Prior Limb Revascularization: Insight From the VOYAGER-PAD Trial
Published on 2026-02-26 First Author Mario Enrico Canonico
Obicetrapib in patients with heterozygous familial hypercholesterolemia: the BROOKLYN randomized clinical trial
Published on 2026-02-26 First Author Stephen J Nicholls
Evaluation of evolocumab on saphenous vein graft patency following coronary artery bypass graft surgery in people living with and without diabetes in the NEWTON-CABG CardioLink-5 trial
Published on 2026-02-19 First Author Hwee Teoh
Novel cholesterol lowering drugs: Can phase 2/3 clinical trial safety assessments predict cardiovascular event outcome trial efficacy?
Published on 2026-02-17 First Author Charles Shear
Multinational Real-World Practice Patterns in the Use of Antithrombotic Therapy Among Patients on Hemodialysis and Peritoneal Dialysis
Published on 2026-02-11 First Author Murilo Guedes
Response to STRIDE: semaglutide in peripheral artery disease and type 2 diabetes - Authors' reply
Published on 2026-02-06 First Author Marc P Bonaca
Impact of peripheral artery disease (PAD) on risk of major adverse cardiovascular events (MACE) in patients with type 2 diabetes
Published on 2026-01-29 First Author James Amamoo
Residual cardiovascular risk in coronary artery disease: from pathophysiology to established and novel therapies
Published on 2026-01-22 First Author Mattia Galli
Association Between the 2022 AHA/ACC/HFSA Heart Failure Staging and Cardiovascular and Kidney Outcomes in Patients With Diabetes and Kidney Disease: A Post Hoc Analysis of the SCORED Randomized Controlled Trial
Published on 2026-01-21 First Author Ayodele Odutayo
Effects of Icosapent Ethyl on Risk and Duration of Hospitalizations and Death in REDUCE-IT
Published on 2026-01-15 First Author Michael Szarek
The Additive Prognostic Value of Lipoprotein(a) for All-cause and Cardiovascular Mortality Across the Traditional Cardiovascular Risk Continuum: Analysis from NHANES III (1988-1994) with Follow-Up to 2019
Published on 2026-01-14 First Author Mustafa Al-Jarshawi
Sex Differences in Spontaneous Coronary Artery Dissection: A Report of the iSCAD Registry
Published on 2026-01-13 First Author Lori M Tam
Improvement in Walking Distance With Semaglutide in Smokers With Peripheral Artery Disease: STRIDE Trial Subgroup Analysis
Published on 2026-01-13 First Author Harald Sourij
Cardiovascular Statistics in the United States, 2026: JACC Stats
Published on 2026-01-11 First Author Rishi K Wadhera
Efficacy of Obicetrapib Across the Spectrum of Background Lipid-Lowering Therapies: Pooled Analyses of the BROADWAY and BROOKLYN Randomized Trials
Published on 2025-12-23 First Author Fotios Barkas
Accelerating evidence generation to implementation: Establishment of the Leading Awareness to Action through Implementation of Cardiometabolic Efforts (LATTICE) consortium
Published on 2025-12-22 First Author Laney K Jones
Management of Peripheral Artery Disease in Adults With Diabetes: 2025 ACC Scientific Statement: A Report of the American College of Cardiology
Published on 2025-12-16 First Author Sandeep R Das
Adjudicated Cardiovascular Events in Patients With COVID-19: Association With Vaccination Status and Changes over Time
Published on 2025-12-10 First Author Behnood Bikdeli
Oxidized Phospholipids, Lipoprotein(a), and Cardiovascular Outcomes After Acute Coronary Syndrome
Published on 2025-11-30 First Author Sotirios Tsimikas
A polygenic risk score for peripheral artery disease and major adverse limb events
Published on 2025-11-27 First Author Samer Al Said
Efficacy and safety of REGN9933A2 and REGN7508Cat for preventing postoperative venous thromboembolism (ROXI-VTE-I and ROXI-VTE-II): two randomised, open-label, phase 2 trials
Published on 2025-11-10 First Author Jeffrey I Weitz
Polygenic Risk Score for Coronary Artery Disease Across the Spectrum of Atherosclerotic Disease
Published on 2025-10-27 First Author Andre Zimerman
Association between Active Cancer and Risk of Thrombotic and Cardiovascular Outcomes in Outpatients with COVID-19: A CORONA-VTE Network Analysis
Published on 2025-10-26 First Author Bridget McGonagle
Rivaroxaban in Peripheral Artery Disease After Revascularization: Worst Events and Net Outcomes in VOYAGER PAD
Published on 2025-10-22 First Author Shea Hogan
Effect of obicetrapib, a potent cholesteryl ester transfer protein inhibitor, on p-tau217 levels in patients with cardiovascular disease
Published on 2025-10-17 First Author Michael H Davidson
Blood pressure, safety and clinical efficacy of vericiguat in chronic heart failure with reduced ejection fraction: Insights from the VICTOR trial
Published on 2025-09-28 First Author Robert J Mentz
Multiplex Apolipoprotein Panel Improves Cardiovascular Event Prediction and Cardiovascular Outcome by Identifying Patients Who Benefit From Targeted PCSK9 Inhibitor Therapy
Published on 2025-09-24 First Author Esther Reijnders
Role of Lipids and Lipid Management Therapy Among Patients With Peripheral Artery Disease: A Reappraisal of the Current Evidence and Future Directions
Published on 2025-09-19 First Author McCall Walker
Association between lipoprotein(a) and cardiovascular events in patients with peripheral artery disease: the Mass General Brigham Lp(a) registry
Published on 2025-09-19 First Author Daniel J McClintick
Peripheral artery disease
Published on 2025-09-18 First Author Victor Aboyans
Drug-Eluting Resorbable Scaffold Versus Balloon Angioplasty for Below-the-Knee Peripheral Artery Disease: 2-Year Results From the LIFE-BTK Trial
Published on 2025-09-10 First Author Brian G DeRubertis
Effect of evolocumab on saphenous vein graft patency after coronary artery bypass surgery (NEWTON-CABG CardioLink-5): an international, randomised, double-blind, placebo-controlled trial
Published on 2025-09-04 First Author Subodh Verma
Pathogenic Cardiomyopathy-Associated Gene Variants and Prognosis in Atrial Fibrillation: Results in 18,000 Clinical Trial Participants
Published on 2025-09-03 First Author Sean J Jurgens
Effect of Vericiguat on Worsening Heart Failure in Compensated Outpatients with HFrEF: Insights from VICTOR
Published on 2025-09-02 First Author Faiez Zannad
Lipoprotein(a) identifies patients with acute coronary syndromes who derive cardiovascular benefit from alirocumab, particularly for limb events
Published on 2025-09-02 First Author Kausik K Ray
Sex Differences in Effectiveness of Semaglutide in Patients with Peripheral Artery Disease: The STRIDE Trial
Published on 2025-09-02 First Author Subodh Verma
Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials
Published on 2025-09-02 First Author Faiez Zannad
Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial
Published on 2025-09-02 First Author Javed Butler
Impact of Obicetrapib on Major Adverse Cardiovascular Events in High-Risk Patients: A Pooled Analysis
Published on 2025-09-01 First Author Stephen J Nicholls
Nonsteroidal and Steroidal Mineralocorticoid Antagonists: Rationale, Evidence, and Unanswered Questions
Published on 2025-08-31 First Author Josephine L Harrington
Vericiguat and mortality in heart failure and reduced ejection fraction: the VICTOR trial
Published on 2025-08-30 First Author Javed Butler
A Polygenic Risk Score to Predict Incident Heart Failure Across the Spectrum of Cardiovascular Risk
Published on 2025-08-27 First Author Paul M Haller
Mobile integrated health for heart failure: insights from the MIGHTy-Heart trial
Published on 2025-08-25 First Author Christian Basile
Effect of PCSK9 Inhibition With Alirocumab in Patients With Probable Familial Hypercholesterolemia or Type III Hyperlipoproteinemia: Results From the ODYSSEY OUTCOMES Trial
Published on 2025-08-23 First Author Gregory P Geba
Response to: 'A call for patient involvement in peripheral artery disease research priority setting'
Published on 2025-08-22 First Author Mary M McDermott
Temporal shift in prevalence of heart failure diagnoses and comorbidities within 2 US integrated health systems
Published on 2025-08-19 First Author Mario Enrico Canonico
Accuracy of Dexcom G6 Pro Continuous Glucose Monitor in the Intensive Care Setting: TIGHT ICU G6 Study
Published on 2025-08-13 First Author Jagdeesh Ullal
International BEST-CLI Collaborative: next steps to create a coordinated global initiative to improve awareness and access while reducing mortality and amputation for patients with chronic limb-threatening ischaemia
Published on 2025-08-12 First Author Michael B Strong
Cardiovascular Risk Factor and Disease Mortality Among Asian Indian, Chinese, and Filipino Adults in the United States, 2018 to 2023
Published on 2025-07-28 First Author Rahul Aggarwal
Digital Therapeutic Based Randomized Investigation to Improve Glycemic Control in Patients With Type 2 Diabetes and Residual Hyperglycemia on Stable Medical Therapy: Rationale, Design, and Baseline Characteristics of the BRIGHT Trial
Published on 2025-07-17 First Author Mario Enrico Canonico
First myocardial infarction: risk factors, symptoms, and medical therapy
Published on 2025-07-03 First Author Nick S Nurmohamed
Health Care Resource Utilization and Costs of Major Adverse Thrombotic Events in Patients with and without ESKD
Published on 2025-06-23 First Author Nicholas S Roetker
Benefit of Semaglutide in Symptomatic Peripheral Artery Disease by Baseline Type 2 Diabetes Characteristics: Insights From STRIDE, a Randomized, Placebo-Controlled, Double-Blind Trial
Published on 2025-06-21 First Author Neda Rasouli
Exercise therapy for symptomatic peripheral artery disease following lower-extremity revascularization in two large healthcare systems
Published on 2025-06-16 First Author Shea E Hogan
Pathways for international medical graduates in U.S. general surgery residency programs: Obstacles and opportunities to overcome them
Published on 2025-06-12 First Author Ioannis A Ziogas
Moving Beyond Glycated Hemoglobin to Glucose Patterns: Newer Indications for Continuous Glucose Monitor Use
Published on 2025-06-06 First Author Shubham Agarwal
Continuous Glucose Monitoring for Prediabetes: Roles, Evidence, and Gaps
Published on 2025-05-23 First Author Salwa J Zahalka
Heart failure with preserved ejection fraction therapeutics: in search of the pillars
Published on 2025-05-21 First Author Abdelghani El Rafei
Dexcom G7 Accuracy and Reproducibility in the Intensive Care Unit
Published on 2025-05-13 First Author Jesica D Baran
Preserving Trial Endpoint Specificity and Cause of Death Attribution in Cardiovascular Trials: Insights From MARINER
Published on 2025-05-13 First Author Shea E Hogan
Safety and Efficacy of Obicetrapib in Patients at High Cardiovascular Risk
Published on 2025-05-08 First Author Stephen J Nicholls
Research priorities for peripheral artery disease: A statement from the Society for Vascular Medicine
Published on 2025-05-01 First Author Mary M McDermott
Hypertension in atherosclerotic cardiovascular disease: insights into epidemiology, management strategies, and outcomes
Published on 2025-04-30 First Author Prerna Gupta
Prescription of aspirin plus low-dose rivaroxaban in patients with peripheral artery disease after lower-extremity revascularization
Published on 2025-04-30 First Author Mario Enrico Canonico
Generalizability of VICTORION-1 PREVENT enrollment criteria to the United States population
Published on 2025-04-15 First Author Rahul Aggarwal
Long-term Antithrombotic Therapy in Patients With Chronic Coronary Syndrome: An Updated Review of Current Evidence
Published on 2025-04-14 First Author Mario Enrico Canonico
Virta Intervention in CommuniTies in ColORado (VICTOR) Pilot Study to Improve Diabetes and Cardiovascular Risk in Rural Communities - Primary Results
Published on 2025-04-10 First Author Cecilia C Low Wang
Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy: An Analysis of the Placebo Arm of ODYSSEY OUTCOMES
Published on 2025-04-07 First Author P Gabriel Steg
Correction to: 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Published on 2025-04-07 First Author Heather L Gornik
Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial
Published on 2025-04-01 First Author Marc P Bonaca
Early Risk of Major Adverse Limb Events Following Lower Extremity Revascularization in the VOYAGER-PAD Trial
Published on 2025-03-21 First Author R Kevin Rogers
Predictors of venous thromboembolic events in hospitalized patients with COVID-19
Published on 2025-03-11 First Author Giovanni Scimeca
Apolipoprotein C3, triglycerides, and cardiovascular risk in optimally treated ACS patients: The critical role of mediation analysis and implications for precision primary prevention: Reply
Published on 2025-03-10 First Author Gregory G Schwartz
Cardiovascular Safety in Oncology Clinical Trials: JACC: CardioOncology Primer
Published on 2025-02-19 First Author Marc P Bonaca
Cardiovascular Outcomes With Icosapent Ethyl by Baseline Low-Density Lipoprotein Cholesterol: A Secondary Analysis of the REDUCE-IT Randomized Trial
Published on 2025-02-19 First Author Rahul Aggarwal
Effect of sotagliflozin on major adverse cardiovascular events: a prespecified secondary analysis of the SCORED randomised trial
Published on 2025-02-17 First Author Rahul Aggarwal
Baseline characteristics of contemporary trial participants with heart failure and reduced ejection fraction: The VICTOR trial
Published on 2025-02-16 First Author Clara I Saldarriaga
Apolipoprotein C3 and risk of cardiovascular events and death in patients on optimized statin treatment after recent acute coronary syndrome
Published on 2025-02-08 First Author Gregory G Schwartz